Hematology
Potential Screening for Tailoring Treatment of AML
Acute Myeloid Leukemia (AML) is a serious disorder of certain blood-forming cells. In this disease, certain early precursor cells in the bone marrow that usually develop into white blood cells do not mature properly. They remain frozen as primitive cells called blasts, unable to further differentiate and mature. More...17 Dec 2018
Unique Genetic Makeup of Myeloma Tumor Cells Profiled
Multiple myeloma is the second-most common type of blood cancer. Multiple myeloma occurs when plasma cells in the bone marrow, the cells that produce antibodies, proliferate out of control and lead to various type of organ failure and death. More...17 Dec 2018
Plasmodium vivax Isolated in Duffy Negative Individuals
Malaria in Nigeria is principally due to Plasmodium falciparum and, to a lesser extent to P. malariae and P. ovale. P. vivax is thought to be absent in Nigeria in particular and sub-Saharan Africa in general, due to the near fixation of the Duffy negative gene in this population. More...12 Dec 2018
Acute Myeloid Leukemia Regulatory Networks Identified
Adult acute myeloid leukemia (AML) is a type of cancer in which the bone marrow makes abnormal myeloblasts (a type of white blood cell), red blood cells, or platelets. AML is a heterogeneous disease caused by a variety of alterations in transcription factors, epigenetic regulators and signaling molecules. More...28 Nov 2018
Malaria Parasitaemia Correlated with Monocyte to Lymphocyte Ratio
In spite of a declining trend in the number of cases and deaths over the last few years, malaria still causes significant mortality and morbidity and the bulk of the burden is observed in children under five years of age. More...28 Nov 2018
Rapid Test for Sickle-Cell Disease Evaluated
Sickle cell disease (SCD) is a common, life‐threatening genetic disorder that is best managed when diagnosed early by newborn screening. Sickle cell disease (SCD) is highly prevalent in sub-Saharan Africa and central India. Sickle cell anemia is the most common and severe form of SCD. More...15 Nov 2018
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
8-Channel Pipette
SAPPHIRE 20–300 µL
In Other News
RNA Defects Linked to Multiple Myeloma Progression
Blood Compatibility Assay Approved by FDA
Functional Genomic Landscape of AML Analyzed
Myeloproliferative Neoplasms Fall into Genetic Subgroups
Prognostic Value of Blood Cell Counts Investigated
Multiple Myeloma Subtypes Linked to Patient Ancestry
Molecular Diagnostics Prevents Malaria in Blood Banks
Next-Gen Test Authorized for Minimal Residual Disease
Automated Microscopy Compared for Routine Malaria Diagnosis
Disease Progression Apprised by Post-Treatment Mutation Sequencing
DNA Test Predicts Risk of Leukemia Relapse
Biomarker Identified for Novel Asthma Treatment
New mRNA Cancer Drivers Revealed in Chronic Lymphocytic Leukemia
Blood Test Predicts Lymphoma Therapy Success
Multi-Omics Approach Guides Relapsed Multiple Myeloma Treatment
Coagulation Tests Affected by Sodium Citrate Concentration
Mutations Identified As Cause for Rare Bone Marrow Disorder
Homogeneous BTK Occupancy Assay Developed
Acute Myeloid Leukemia Risk Predicted in Healthy Individuals
Hematological Parameters Predict Severity of Acute Pancreatitis
FDA Recommends Pooled Blood Testing of Zika Screening
Biochemical Changes in Stored Donor Units Analyzed
Two Viral Blood Screening Assays Get FDA Clearance
The Hematology channel at LabMedica covers the all aspect of plasma, coagulation, transfusion medicine, and blood banking, as well as related lab tools and techniques.